Obstetrics & Gynaecology · Cervical Carcinoma (Risk Factors, Staging, Treatment)

A 35-year-old woman has Stage IB2 cervical cancer (tumor 5.5 cm, confined to cervix on imaging). Which is the recommended primary treatment according to current guidelines?

  • A Concurrent chemoradiation (cisplatin + external beam radiotherapy + brachytherapy)
  • B Radical hysterectomy with pelvic lymph node dissection
  • C Neoadjuvant chemotherapy followed by radical hysterectomy
  • D Simple hysterectomy followed by adjuvant radiotherapy
Correct answer: A. Concurrent chemoradiation (cisplatin + external beam radiotherapy + brachytherapy)

Explanation

For locally advanced cervical cancer including FIGO 2018 Stage IB3 (≥4 cm), concurrent chemoradiation is the standard primary treatment. Stage IB2 (4–5 cm) in FIGO 2018 overlaps with what was called IB2 previously. For bulky Stage IB2/IB3 tumors, the Sedlis criteria and GOG studies show concurrent cisplatin-based chemoradiation with brachytherapy achieves equivalent or better outcomes with less morbidity than surgery. Surgery is preferred for Stage IB1 (< 4 cm).

Reference: Shaw's Textbook of Gynaecology, 17th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs

See all Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs →